# HCV Reinfection After DAA Therapy in PWID in Belgium

> **NCT04251572** · NA · UNKNOWN · sponsor: **Hasselt University** · enrollment: 100 (estimated)

## Conditions studied

- Hepatitis C Virus Infection, Response to Therapy of
- Drug Use

## Interventions

- **OTHER:** Blood sampling
- **OTHER:** questionaires

## Key facts

- **NCT ID:** NCT04251572
- **Lead sponsor:** Hasselt University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-01
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-08-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04251572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04251572, "HCV Reinfection After DAA Therapy in PWID in Belgium". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04251572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*